back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-06-15 16:00 Tx date 2022-05-20 |
$LEXT
Lexston Life Sciences Corp. |
Remenda, Kyle
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-5,040,800 vol |
1,260,200 | |
| Filed 2022-06-15 15:56 Tx date 2022-05-18 |
$LEXT
Lexston Life Sciences Corp. |
Remenda, Kyle
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-222,222 vol |
0 | |
| Filed 2022-01-14 12:41 Tx date 2022-01-10 |
$LEXT
Lexston Life Sciences Corp. |
Remenda, Kyle
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,480
-44,000 vol $0.17 each |
6,301,000 | |
| Filed 2022-01-14 12:40 Tx date 2022-01-06 |
$LEXT
Lexston Life Sciences Corp. |
Remenda, Kyle
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,100
-30,000 vol $0.17 each |
6,345,000 | |
| Filed 2022-01-14 11:54 Tx date 2022-01-10 |
$LEXT
Lexston Life Sciences Corp. |
Remenda, Kyle
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-748,000
-44,000 vol $17.00 each |
6,301,000 | |
| Filed 2022-01-14 11:54 Tx date 2022-01-10 |
$LEXT
Lexston Life Sciences Corp. |
Remenda, Kyle
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-748,000
-44,000 vol $17.00 each |
||
| Filed 2022-01-14 11:53 Tx date 2022-01-06 |
$LEXT
Lexston Life Sciences Corp. |
Remenda, Kyle
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-510,000
-30,000 vol $17.00 each |
6,345,000 | |
| Filed 2022-01-14 11:53 Tx date 2022-01-06 |
$LEXT
Lexston Life Sciences Corp. |
Remenda, Kyle
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-510,000
-30,000 vol $17.00 each |
||
| Filed 2021-06-21 12:34 Tx date 2021-06-17 |
$
Lexston Life Sciences Corp. |
Remenda, Kyle
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
222,222 | ||
| Filed 2021-06-21 12:14 Tx date 2021-06-17 |
$
Lexston Life Sciences Corp. |
Remenda, Kyle
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,375,000 | ||
| Filed 2017-06-16 Tx date 2017-01-16 |
$
Capha Pharmaceuticals Inc. (Formerly FPS PHARMA INC.) |
Remenda, Kyle Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-16 Tx date 2017-01-16 |
$
Capha Pharmaceuticals Inc. (Formerly FPS PHARMA INC.) |
Remenda, Kyle Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-16 Tx date 2017-01-16 |
$
Capha Pharmaceuticals Inc. (Formerly FPS PHARMA INC.) |
Remenda, Kyle Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|